Recent development of monoamine oxidase inhibitors

By Bolasco Adriana   Fioravanti Rossella   Carradori Simone  

Expert Opinion on Therapeutic Patents, Vol. 15, Iss. 12, 2005-12 ,pp. : 1763-1782

Informa Healthcare

Access to resources Recommend Favorite

Monoamine Oxidase Inhibitors as Neuroprotective Agents in Age-Dependent Neurodegenerative Disorders

By  

Current Pharmaceutical Design, Vol. 16, Iss. 25, 2010-08 ,pp. : 2799-2817

Bentham Science Publishers

Access to resources Recommend Favorite

D-Amino Acid Oxidase Inhibitors as a Novel Class of Drugs for Schizophrenia Therapy

By  

Current Pharmaceutical Design, Vol. 19, Iss. 14, 2013-04 ,pp. : 2499-2511

Bentham Science Publishers

Access to resources Recommend Favorite

Neuroprotective and neurotoxic effects of monoamine oxidase-B inhibitors and derived metabolites under ischemia in PC12 cells

By Abu-Raya S.   Tabakman R.   Blaugrund E.   Trembovler V.   Lazarovici P.  

European Journal of Pharmacology, Vol. 434, Iss. 3, 2002-01 ,pp. : 109-116

Elsevier

Access to resources Recommend Favorite

Monoamine Oxidase Inhibitors Extracted from Tobacco Smoke as Neuroprotective Factors for Potential Treatment of Parkinson’s Disease

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 14, Iss. 6, 2015-01 ,pp. : 777-785

Bentham Science Publishers

Access to resources Recommend Favorite